Hyprotigen 5%

   
Google
 
Web NewDrugInformation.com

Hyprotigen 5%


Drug - Hyprotigen 5%
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Protein Hydrolysate
Multiple ingredients are in alphabetical order.

Strength - 5%
The potency of the active ingredient(s), Protein Hydrolysate. May repeat for multiple part products.

Applicant - B BRAUN
The firm name holding legal responsibility for Hyprotigen 5%. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 006170
The FDA assigned number to Hyprotigen 5%. Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Hyprotigen 5%. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 10, 1984
The date Hyprotigen 5% was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hyprotigen 5%. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hyprotigen 5% is in. Format is RX, OTC, DISCN.

Applicant Full Name - B Braun Medical Inc
The full name of the firm holding legal responsibility for the new application of Hyprotigen 5%.

Hyprotigen 5%